Population pharmacokinetics of recombinant factor VIII Fc fusion protein

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 163-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®): A Review of its Use in the Management of Patients with Haemophilia A

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 987-1007

Adis International

Access to resources Recommend Favorite

Facts on factor VIII prevention of haemophilic arthropathy

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A: Comparison with B-Domain Deleted rFVIII, and Value of Potential Viral Transmission Reduction due to Plasma/Albumin-Free Status

By Sclar David A.   Evans Marc A.   Skaer Tracy L.   Robison Linda M.   Chung Karen C.   Poulios Nick S.  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite

Immunogenicity and pharmacokinetic studies of recombinant Factor VIII containing lipid cochleates

By Kosloski Matthew P.   Peng Aaron   Varma Prashant R.   Fathallah Anas M.   Miclea Razvan D.   Mager Donald E.   Balu-iyer Sathy V.  

Drug Delivery, Vol. 18, Iss. 4, 2011-05 ,pp. : 246-254

Informa Healthcare

Access to resources Recommend Favorite